Key result
South Asians have approximately a 2-fold higher risk of atherosclerotic cardiovascular disease compared with other populations, prompting the development of tailored clinical programs in the US.
Why the study?
South Asians face approximately a 2-fold higher risk of atherosclerotic CVD, leading to specialized US clinical programs whose key characteristics and programmatic gaps need summarizing.
Dedicated clinical programs for South Asian Americans incorporate culturally tailored components to address their 2-fold higher risk of atherosclerotic CVD.
Answers are grounded in this paper and cite their sources.
May guide culturally tailored CVD programs for South Asians; leaves open need for controlled outcome trials before adoption.
Medical literature shows that South Asians have approximately a 2-fold higher risk of atherosclerotic cardiovascular disease (CVD) compared with other populations. Given this high prevalence, clinical programs to promote cardiovascular health have emerged in the United States that are dedicated to clinical care for South Asian individuals. In this review, we have summarized the key characteristics of clinical programs in the U.S. dedicated to preventing and managing CVD in South Asian American patients. These clinical centers have many unique components in common that are catered to South Asian patient populations including ethnicity concordance of clinical providers, intensive cardiovascular screening protocols with laboratory studies and potentially genetic testing, dieticians and nutritionists who are familiar with South Asian-style dietary patterns, health coaches to support behavior change, community outreach programs, and involvement in clinical research to learn further about risk factors, prevention, and treatment of cardiovascular disease in South Asian populations. There are still many evidence and programmatic gaps left to uncover in the prevention, diagnosis, and management of CVD in South Asian. This review provides guidance for important features, barriers, and facilitators for future cardiovascular centers to develop in the United States where they can serve South Asian populations.
No takes yet. Share an insight, caveat, or question.
Gulati et al. (2023) conducted a review in Atherosclerotic cardiovascular disease. Clinical programs for cardiometabolic health was evaluated. South Asians have approximately a 2-fold higher risk of atherosclerotic cardiovascular disease compared with other populations, prompting the development of tailored clinical programs in the US.
Synapse has enriched 10 related papers. Consider them for comparative context: